SCHEMBL5653909

SCHEMBL5653909

CCOC(=O)c1sc2c(ccc(=O)n2-c2ccc(Br)cc2)c1-c1ccc(F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
PTGER1 P34995 4/20 0.38
ALOX5 P09917 3/20 0.38
MAPT P10636 5/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651315 0.91 MAPT (0.43) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5653071 0.87 TRPV4 (0.41) ALDH1A1HPGDALOX15HSD17B10TSHR
Hydrochloric Acid SCHEMBL5653006 0.86 TRPV4 (0.40) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5649662 0.83 MAPT (0.43) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5654208 0.81 MAPT (0.47) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5652339 0.81 MAPT (0.44) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL1266825 0.80 MAPT (0.41) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5647895 0.79 MAPT (0.41) ALDH1A1HPGDALOX15HSD17B10TSHR
SCHEMBL5652293 0.79 MAPT (0.44) ALDH1A1HPGDHSD17B10NPSR1MAPT
SCHEMBL5652325 0.77 MAPT (0.47) ALDH1A1HPGDNPSR1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176215-B2 Bicyclic oxopyridine and oxopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2007-02-13 US disclosed
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives UCB PHARMA S.A. (BE) 2004-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives MAPK1, ALK, NAT1 ALDH1A1 1498/4885HPGD 1929/4885ALOX15 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.